Introduction
============

Olfactomedin-like 3 (*OLFML3*) is a member of the olfactomedin-like gene family, containing an olfactomedin(OLF) domain in the C-terminal region and a less well conserved coiled-coil domain in the N-terminal region [@B1]. Since olfactomedin was first cloned from frog olfactory tissue [@B2], more than 100 known OLF members have been discovered in various species ranging from *Caenorhabditis elegans* to *Homo sapiens* [@B3]. Many OLF members have been demonstrated to play important roles in various physiological processes. Myocilin, a member of OLF family, is similar to *OLFML3* in structure, and the mutations of its protein are closely associated with primary open angle glaucoma and the identification will aid in early diagnosis [@B4]-[@B8]. Noelin plays an important role in neural development [@B9], [@B10]. The *OLFML3* gene, also known as *HNOEL-iso* and *hOLF44*in humans [@B11], *ONT3* in mice [@B12] and *ONT1* in chicken and *Xenopus* [@B13], [@B14], was dropped into subfamily VII on the basis of phylogenetic analysis [@B3]. Furthermore, the *OLFML3* gene may have important roles in embryonic development [@B3], however, to our knowledge, the functional properties and regulation mechanism of *OLFML3* gene remained unclear.

The gene expressions are mediated by many factors, such as transcription factors, microRNA and methylation. MicroRNAs (miRNAs) are evolutionary conserved small noncoding RNAs of 21- to 23- nucleotides that regulate genes expression by inhibiting translation of target messenger RNA (mRNA) transcripts binding to the 3′-untranslated regions (3′UTRs), leading to mRNA cleavage, translational repression, or both [@B15]. In recent years, miRNAs have emerged as critical regulators of gene expression. They regulate 30% of all animal genes in a variety of biological processes, including development, immunity, cell differentiation, apoptosis, metabolism and signal transduction [@B16]-[@B21]. Many studies documented that miRNAs play important roles in mammalian skeletal muscle development [@B22]-[@B26]. Bioinformatics prediction showed that *OLFML3* was regulated by *miR-155*. MiR-155, a typical multifunctional miRNA, has been proved to be associated with cell cycles [@B27] and may accelerate cell proliferation [@B28] and myogenic differentiation [@B29].

In the present study, we first cloned and analyzed porcine *OLFML3* gene and investigated its spatial distribution in adult Tongcheng pigs and dynamical expression patterns during skeletal muscle development (22 stages) from Landrace (lean-type) and Tongcheng (obese-type) pigs by real-time polymerase chain reaction (PCR). Subsequently, dual luciferase reporter assay and real-time PCR were used to explore the interaction between *OLFML3* and miR-155 in PK15 and PIEC cells. The facts suggested that *OLFML3* gene may affect prenatal skeletal muscle development and was regulated by miR-155 at mRNA level in pig.

Materials and methods
=====================

Animal samples and data collection
----------------------------------

All animals were treated according to the animal procedures defined by national and local animal welfare bodies, and all animal work was approved by the Hubei Province, P. R. China for Biological Studies Animal Care and Use Committee.

Twelve tissues, including heart, liver, spleen, lung, kidney, stomach, fat, longissimus dorsi, small intestines, pancreas, placenta and uterus were collected from three adult Tongcheng pigs for spatial expression analysis. After copulation with the boar of each corresponding breed, the pigs were then sacrificed at a commercial slaughterhouse at the selected stages. Skeletal muscle at twelve prenatal developmental stages ( 33, 40, 45, 50, 55, 60, 65, 70, 75, 80, 90 and 100 days post coitus (dpc)) and ten postnatal stages ( 0, 9, 20, 30, 40, 60, 80, 120, 160 day and adult) from Landrace pigs and Chinese indigenous Tongcheng pigs were collected for dynamical expression analysis. All the tissue samples were harvested, immediately frozen in liquid nitrogen, and then stored at -80℃ until used.

Identification and isolation of porcine *OLFML3* gene
-----------------------------------------------------

From our LongSAGE library of swine prenatal skeletal muscle [@B30], [@B31], a differently expressed tag (GGACTCCAGATCTTGAG) that potentially represented the *OLFML3* gene was selected for further analysis. We converted this tag sequence into its corresponding 3′cDNA by using the GLGI (generation of longer cDNA fragments from SAGE tags for gene identification) method [@B31]. Primers (G*LGI*-F, *GLGI*-R, Table [1](#T1){ref-type="table"}) were used to amplify the sequences, which were then subjected to basic local alignment search tool (BLAST) searches for gene identification. To validate the GLGI result and obtain the 3′UTR, SMART RACE technology (Clontech, Palo Alto, CA, USA) was used to clone porcine *OLFML3* transcripts containing the 3′-end. For first-strand cDNA synthesis and the porcine *OLFML3* gene sequence obtained earlier, a gene-specific primer was designed for the 3′-RACE PCR (*3*′-GSP, Table [1](#T1){ref-type="table"}). Reverse transcriptase and PCR were carried out according to the instruction manual of the SMART RACE cDNA amplification kit. The 3′-RACE products were gel-purified prior to sequencing.

Porcine expression sequence tags (ESTs) were obtained by using the basic local alignment search tool (BLAST) algorithm (<http://blast.ncbi.nlm.nih.gov/>) and the human mRNA sequence of *OLFML3* (olfactomedin-like 3, GenBank accession no. NM_020190.2). The porcine ESTs that shared more than 80% sequence identity with human mRNA were selected and assembled using the Seqman program (DNAStar, Inc., Madison, WI, USA). Primer pairs (*CDS*-F, *CDS*-R, Table [1](#T1){ref-type="table"}) were designed from the assembled EST contigs by using Primer 5.0 software to amplify the porcine *OLFML3* cDNA sequence from longissimus dorsi of Tongcheng pigs. PCR was performed in a volume of 10 µL containing l µL 10 × PCR buffer (Mg^2+^ plus), 0.8 µL 2.5 mM dNTP mix, 0.3 µL of each PCR primer (100 ng/µL), 0.1 µL 5 U r-Taq DNA polymerase (Fermentas, Vilnius, Lithuania), 1 µL cDNA and 6.5 µL sterile water. The PCR reaction conditions were 5 min at 95 °C, followed by 26 cycles at 94℃ for 30 s, 60℃ for 30 s, 72℃ for 1 min, and followed by a final extension of 72℃ for 5 min. The PCR products were purified and subsequently cloned into the pMD18-T vector (Trans, Beijing, China) and seeded on Ampicillin plates. Minipreps were obtained from colonies grown in 1 ml LB-Amp broth for sequencing.

Bioinformatics analysis
-----------------------

The TargetScan program (Version 5.1) (<http://www.targetscan.org/>) and PicTar WEB INTERFACE (<http://pictar.mdc-berlin.de/cgi-bin/PicTar_vertebrate.cgi?species=vertebrate&from_data=target> predictions for all human microRNAs based on conservation in mammals (human, chimp, mouse, rat, dog)) were used to scan potential miRNA target sites for the *OLFML*3 gene with the default parameters [@B32]. The results showed that *OLFML3*gene was targeted by only miR-155 and contains a match with nucleotides 2 to 7 of the miRNA with the target sequences (G: U base-pairing was tolerated) in both human and mouse. Furthermore, there is remarkable conservation of the *OLFML3* 3\'UTR sequence from *Xenopus tropicalis* to *human* within and around the predicted miR-155 target site, and the seed sequences of *miR-155*are also highly evolutionarily conserved across multiple species. Consequently, the *OLFML*3 gene containing the miR-155 binding site within its 3\'UTRs in pig was further analyzed.

Plasmid construct
-----------------

A fragment of 485 bp encompassing the entire *OLFML3* 3\'UTR was cloned from Tongcheng pig genomic DNA using gene-specific primers (*3′-UTR*-F, *3′-UTR*-R, Table [1](#T1){ref-type="table"}) and inserted downstream of the Renilla Luciferase ORF in the *psiCHECK-2* vector (Promega, Madison, WI, USA) using the *Not*I and *Xho*I restriction sites. For detecting the fold change of *OLFML3* mRNA, the Renilla luciferase ORF in the *psiCHECK-2* vector was replaced with the *OLFML3* CDS with *Nhe*I and *Xho*I sites. The sequence of porcine miR-155 was obtained according to miRBase (<http://www.mirbase.org/>) (ssc-mir-155, MI0015907) [@B33]. The approximately 653bp sequence, which included the miR-155 hairpin precursor and its native flanking sequence, were amplified by PCR from Tongcheng pig genomic DNA (*ssc-miR-155*-F, *ssc-miR-155*-R, Table [1](#T1){ref-type="table"}) and subcloned into the *pcDNA3.1 (+)* (Invitrogen, Carlsbad, CA, USA) expression vector. All sequences were confirmed by DNA sequencing.

Cell culture
------------

PK15 (porcine kidney epithelial cell line) and PIEC (porcine iliac endothelial cell line, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, P. R. China) were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) with high glucose (Gibco, Invitrogen, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (Gibco, Invitrogen, Carlsbad, CA, USA) and 1% glutamine, in a 37°C incubator with 5% CO~2~.

Luciferase assay
----------------

PK15 and PIEC cells were seeded at 8 × 10^4^ cells per well in 24-well plates (Corning Incorporated, NY, USA), 24 h after the plating, cells were transfected by FuGENE^®^ HD Transfection Reagent (Roche, Basel, Switzerland) according to the manufacturer\'s instructions. In each well, 100 ng *psiCHECK-2*-*3\'UTR* or mutant and 400 ng *pcDNA3.1 (+)-miR-155* or *pcDNA3.1*(+) vector (control) were cotransfected. After transfection for 36 h, cells were harvested by the addition of 500 μL passive lysis buffer. Renilla and firefly luciferase activities in the cell lysate were measured with the Dual Luciferase assay system (Promega, Madison, WI, USA) in a TD-20/20 luminometer (Turner Biosystems, Sunnyvale, CA, USA) and the Renilla luciferase signal was normalized to the firefly luciferase signal. The normalized Renilla luciferase activity was compared with the control, miR-155 and mutant using the Student\'s *t*-test (p\<0.05).

Real-time quantitative PCR
--------------------------

To detect whether the *OLFML3* mRNA levels were affected by overexpression of miR-155, we seeded PK15 cells into 12-well plates; and after transfection for 48 h, total RNA was harvested and detected by real time PCR. The manipulation was performed in triplicate to confirm the result. The tissues distribution and dynamical expression of *OLFML3* were also assayed by RT-PCR.

Total RNA was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA, USA); 1ug total RNA was reverse transcribed in a final volume of 20 µl using the RevertAid First Strand cDNA Synthesis Kit (Fermentas, Vilnius, Lithuania). Gene-specific primers (*EXP*-F, *EXP*-R and *GAPDH*-F, *GAPDH*-R, Table [1](#T1){ref-type="table"}) were designed for quantitative PCR. Each real-time PCR reaction was performed in a final volume of 20 µl reaction mixture containing SYBR Premix Ex Taq (2×), Rox Reference Dye Ⅱ (50×) (TaKaRa, Dalian, China), gene-specific primers, template cDNA and sterile water. The PCR amplification was performed on a 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) under the following cycling conditions: 30 s at 95 °C, followed by 40 cycles at 95 °C for 5 s, 60 °C for 30 s and 72 °C for 34 s. RT-PCRs were performed in triplicate and porcine glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*) was amplified as an internal control.

The overexpression levels of mature miR-155 were determined by stem-loop real-time PCR [@B34]. After the reverse transcription reaction, the level of miR-155 was detected using a 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) under the following conditions: after an initial denaturation at 95 °C for 30 s, the amplification was performed by denaturation at 95 °C for 5 s, annealing and extension at 56 °C for 34 s for 40 cycles. The expression levels of *U6* small nuclear RNA (*U6* snRNA) were also determined by real-time PCR and were used to normalize the miR-155.

Gene expression levels were quantified relative to internal control expression using Gene Expression Macro software (Bio-Rad, Richmond, CA, USA), and the results were analyzed by the 2^-△△Ct^ method [@B35].

Results
=======

Sequence characterization of porcine *OLFML3* gene
--------------------------------------------------

The sequence obtained from GLGI and 3′-RACE has 72% and 82% of identical to sequence from *Homo sapiens OLFML3*, respectively, suggested that the LongSAGE tag represented the swine *OLFML3* gene. Compared with the available cDNA and DNA sequences of human and mouse *OLFML3*, a total of 2,872-bp genomic sequences, including three exons and two introns, were cloned in our experiment (GenBank accession no. JN699054). Sequence analysis revealed that porcine *OLFML3* cDNA comprised a 1224-bp open reading frame (ORF) flanked by a 120-bp 5′UTR and 500-bp 3′UTR sequences, with a consensus ATTAAA polyadenylation signal 16 bp upstream of the poly (A) stretch. Porcine *OLFML3* gene shows 86% and 87% identity with human (NM_020190.2) and mouse (NM_133859.2) counterparts, respectively. Further comparison revealed that each of the 5′-donor and 3′-acceptor splice sites conformed to the GT-AG rule (Table [2](#T2){ref-type="table"}). Porcine *OLFML*3 was predicted to encode a polypeptide of 407 amino acid residues with a calculated molecular mass of 45.9 kD and an isolectric point of 6.6765. The predicted porcine OLFML3 polypeptide exhibits 94%, 94%, 92%, 94% and 65% similarity with human (NP_064575.1), cattle (NP_001068665.1), mouse (NP_598620.2), rat (NP_001101178) and gallus (NP_001035107.1) homologues, respectively. Amino acid sequence analysis also showed that the precursor protein of OLFML3 contains coiled coil region and Olfactomedin-like domain, similar to the domains of the human and mouse (Fig. [1](#F1){ref-type="fig"} and Fig. [2](#F2){ref-type="fig"}).

Tissue distribution and dynamical expression of *OLFML3* gene
-------------------------------------------------------------

Quantitative real-time PCR analysis showed that porcine *OLFML3* mRNA expression varied greatly in diverse tissues, it was highly expressed in liver and pancreas, moderately in lung, small intestines and placenta, and weakly in other tissues (Fig. [3](#F3){ref-type="fig"}). As shown in Fig. [4](#F4){ref-type="fig"}, the *OLFML3* gene exhibited different dynamical expression patterns in prenatal skeletal muscle and a lower level in post-natal stages between Landrace and Tongcheng pigs. In the prenatal skeletal muscle development of Landrace pigs, the *OLFML3* was down-regulated during 33-50 days, subsequently up-regulated during 50-70 days, and then down-regulated during 70-100 days. While in Tongcheng pigs, the *OLFML3* was down-regulated at 33-50 dpc, subsequently up-regulated at 50-55 dpc and then down-regulated at 55-100 dpc. Moreover, there was higher expression in prenatal muscle of 33-60 dpc in Tongcheng pigs than in Landrace, while this expression pattern is reversed at 65-100 dpc.

*OLFML3*was a target of microRNA-155
------------------------------------

Using TargetScan and PicTar target prediction programs, *OLFML3* was identified as a putative miR-155 target in human and mouse. The target site between *OLFML3* and miR-155 is highly conserved among mammals (Fig. [5](#F5){ref-type="fig"}). To validate whether *OLFML3* is directly targeted by miR-155 in pig, a dual luciferase assay was performed in PK15 and PIEC cells. The result showed that the luciferase activity of *psiCHECK-2*, which contains the *OLFML3* 3\'UTR sequence, was significantly decreased (65.1% of control in PK15 and 62.9% of control in PIEC cell line). To further validate the specific target site, we mutated the binding sites of the *OLFML3* 3\'UTR and the results indicated that the luciferase activity of *psiCHECK-2*, which contains the mutant, was not affected by miR-155 (Fig. [6](#F6){ref-type="fig"}).

Since *OLFML3* is a target of miR-155, we investigated whether endogenous mRNA levels of *OLFML3* were affected by the overexpression of miR-155. PK15 cells were transfected with control and miR-155 overexpression vectors, and total cellular RNA was harvested 48 h after transfection. Mature miR-155 and *OLFML3* mRNA levels were tested by RT-PCR. The result showed that overexpression of miR-155 down-regulated *OLFML3* mRNA to 60% of the level in control cells (Fig. [7](#F7){ref-type="fig"}). To validate this result, we cotransfected the miR-155 overexpression vector and *psiCHECK-2*, which contains the *OLFML3* mRNA sequence, in the PK15 cells, real-time PCR results suggested that the *OLFML3* mRNA level was downregulated 61% of the level in control cells by overexpression of *miR-155* (Fig. [7](#F7){ref-type="fig"}). These results documented that the *OLFML3* gene was regulated by miR-155 in pigs.

Discussion
==========

The results of our study provide the complete fundamental structure of the porcine *OLFML3* gene. Comparison of its genome structure with that human *OLFML3*, demonstrated remarkably high similarity between the two species; they both contained three exons and two introns. The coding sequence (CDS) region and the deduced amino acid sequence of porcine *OLFML3* shared 92% and 94% identity to that of human respectively. The Olfactomedin-like domain, may be involving intracellular accumulation of folded proteins [@B36], is highly conserved among human, mouse and pig.

Comparing our results with human and mouse *OLFML3* microarray expression data (<http://genome.ucsc.edu/>), we found that the expression pattern of porcine *OLFML3* gene was partial coincided with the expression of the corresponding gene in human and mouse, it was expressed at considerable levels in liver and lung. Our results were also in agreement with the northern blot analysis results in human tissues [@B11].

*OLFML3* gene play an important roles in embryonic development [@B3], our study documented that it exhibits different expression patterns during prenatal skeletal muscle development from Landrace to Tongcheng pigs, indicating that *OLFML3*may affect prenatal skeletal muscle development in porcine. The previous studies showed that the establishment of the total number of fibers involves two major waves of fiber generation: primary muscle fiber formation at 35-60 dpc and secondary muscle fibers assembled at 54-90 dpc [@B37]-[@B39], the expression patterns of *OLFML3* gene during prenatal skeletal muscle development in our study indicating that it mainly involved in the formation of primary muscle fibers. The differential expression patterns from Landrace to Tongcheng pigs also showed that there are developmental synchronizations in prenatal skeletal muscle development between the two pig breeds, the result was consistent with our previous report [@B31], [@B40], which concluded Landrace pigs may have a quicker muscle growth rate than Tongcheng pigs. Prenatal muscle development programs postnatal performance. The total number of fibers was fixed by the number of primary muscle fibers before birth in pig [@B37]. The facts documented that *OLFML3* may affect the phenotype of postnatal muscle in different pig breeds.

Previous studies have reported that miRNA play important roles in gene expression regulation. However, the expression and regulation mechanism of *OLFML3* gene in pig have not been reported. Our study documented that *OLFML3* expression was regulated by miR-155. The overexpression of miR-155 decreased the luciferase activity of *psiCHECK-2*, which contains the *OLFML3* 3\'UTR sequence, and the suppression level was similar to that observed in other studies [@B41]. Moreover, the miR-155 overexpression vector did not decrease the luciferase activity of *psiCHECK-2* with the *OLFML3* 3\'UTR mutant sequence, indicating that the target site is specific and unique in porcine. However, we do not exclude the possibility that additional miR-155-independent effects (e.g., mRNA stability, alteration of RNA secondary structure, or disruption/addition of a binding site for an unknown regulatory factor) may be attributed to specific point mutations introduced in the *OLFML3* 3\'UTR[@B42]. Furthermore, the overexpression of miR-155 significantly decreased the *OLFML3* mRNA level in PK15 cells, indicating that the downregulation of *OLFML3* by miR-155 may be due to the mRNA degradation. The results are similar to those of previous reports of miRNA-dependent mRNA degradation in other systems [@B43]. MiR-155-mediated *OLFML3* mRNA degradation is probably performed by mRNA degradation machinery, because the miRNA-mediated mRNA degradation in mammals is not thought to involve endonucleolytic cleavage [@B44]. Previous studies have proved that miR-155 may accelerate cell proliferation and differentiation [@B28], [@B29], and therefore, we speculated that *OLFML3* was regulated by miR-155 and involved in proliferation of muscle cells and further affect prenatal skeletal muscle development. Moreover, we have tried to explore the interaction between *OLFML3* and miR-155 at the protein level, however, without the antibody in pigs, we have not obtained the target strip with Olfactomedin-like antibody in human (GTX120065, GeneTex, CA, USA). The sequences of the 3\'UTR of *OLFML3* gene around the miR-155 target sites and the seed sequence of mature miR-155 are well conserved in mammals, suggesting that the target region is probably important in *OLFML3* regulation, and the regulation of *OLFML3* by miR-155 may exist in other species.

In conclusion, we reported the molecular characterization of the porcine *OLFML3* gene and found that *OLFML3* exhibits different expression patterns during prenatal skeletal muscle development between Landrace and Tongcheng pigs, indicating that *OLFML3* gene may affect prenatal skeletal muscle development. These facts also suggested that *OLFML3*may contribute to muscle phenotype with different genotype breed pigs. Finally, we have verified that porcine*OLFML3* mRNA expression was regulated by miR-155. Overall, our work provides fundamental data regarding *OLFML3* and miR-155 and suggests that *OLFML3* gene may affect muscle development of pig.

The authors thank Dr. Jianhua Cao in Huazhong Agricultural University for providing psiCHECK-2 vector. This work was supported by National Natural Science Foundation of China (31171192, 30830080), National Key Project (2011ZX08009-001) and National Basic Research Program of China (No. 2009CB941604).

![Deduced amino acid sequence of porcine *OLFML3* compared with mouse *OLFML3* (GenBank accession no. NP_598620.2) and human *OLFML3* (GenBank accession no. NP_064575.1). Shading shows identical amino acid residues among the three species. Common structural domains are indicated by boxes including coiled coil region and Olfactomedin-like domains.](ijbsv08p0459g01){#F1}

![Phylogenetic tree and domain of porcine OLFML3 protein. (a) Phylogenetic tree of OLFML3 in different species. The GenBank accession numbers of those sequences are as follows: human: NP_064575.1, cattle: NP_001068665.1, rat: NP_001101178.1, mouse: NP_598620.2, Gallus: NP_001035107.1. The porcine OLFML3 amino acid sequence was deduced from the full cDNA sequence in this study. (b) Domain of porcine OLFML3 protein. The porcine OLFML3 precursor protein contains coiled coil region and Olfactomedin-like domain.](ijbsv08p0459g02){#F2}

![*OLFML3* expression in different tissues of the adult Tongcheng pig. Tissues were (1) heart, (2) liver, (3) spleen, (4) lung, (5) kidney, (6) stomach, (7) fat, (8) longissimus dorsi, (9) small intestines, (10) pancreas, (11) uterus, and (12) placenta. The values are the average (±SE) levels of *OLFML3* normalized to *GAPDH* from three independent experiments. The value of *OLFML3* in heart was arbitrarily set to 1.0.](ijbsv08p0459g03){#F3}

![Relative *OLFML3* mRNA expression level in porcine skeletal muscle from Landrace and Tongcheng pigs at different developmental stages. Expression was normalized to *GAPDH* and expression levels are the average (±SE) of three independent experiments during all stages. The value of *OLFML3* in adult of Tongcheng pigs was arbitrarily set to 1.0. pf, post- fecundation; pn, post-natal.](ijbsv08p0459g04){#F4}

![*OLFML3* 3\'UTR has conserved *miR-155* target sites. (a) *OLFML3* was predicted as a target of *miR-155* using the PicTar. (b) *OLFML3* was predicted as a target of *miR-155* using TargetScan program (Version 5.1). (c) The complementary site for*OLFML3* and *miR-155* was mapped using DNAMAN. The upper part represents *OLFML3* and the lower part represents *miR-155*. The corresponding plot shows conservation across species.](ijbsv08p0459g05){#F5}

![*OLFML3* is a primary target for *miR-155*. **a**. Schematic representation of the construct used in the luciferase assay. A 485-bp region of the porcine *OLFML3* 3\'UTR containing one putative *miR-155* target site was cloned into the *psiCHECK-2* vector. **b**. Overexpression of porcine *miR-155* in PK15 and PIEC cells. Histogram indicates overexpression of *miR-155* after transfection for 48 h. Mature *miR-155* was analyzed by real-time PCR. **c**. miR-155:OLFML3 3\'UTR duplex. The sequence marked in red is *OLFML3* 3\'UTR, and the sequence marked in green is the seed sequence of *miR-155* in human. **d.** Cotransfection of porcine *pre-miR-155* or control and porcine *OLFML3* 3\'UTR-derived *psiCHECK-2* construct or mutant in PK15 and PIEC cells. Renilla activity at 48 h post-transfection shows a significant decrease in normalized values than in control and mutant in both cell types. Five replicates were performed for each group and the experiment was repeated at least three times. \*\* indicates a p-value of less than 0.01 in a Student\'s *t-*test.](ijbsv08p0459g06){#F6}

![*MiR-155* regulates *OLFML3* at the mRNA level. **a**. Transfection of porcine *pre-miR-155* in PK15 cells shows a significant decrease in the normalized endogenous*OLFML3* mRNA level. **b**. Cotransfection of porcine *pre-miR-155* and porcine *OLFML3* -CDS-3′UTR- psiCHECK-2 construct in PK15 cells shows a significant decrease in the normalized *OLFML3* mRNA level. Three replicates were performed for each group and the experiment repeated at least three times. \* indicates a p-value of less than 0.05 in a Student\'s *t-*test and \*\* indicates a p-value of less than 0.01 in a Student\'s *t-*test.](ijbsv08p0459g07){#F7}

###### 

Primers information in experiments.

  Primer symbol      Primer sequence(5′-3′)                         Binding region   Size(bp)   PCR(TM)(℃)
  ------------------ ---------------------------------------------- ---------------- ---------- ------------
  *5′UTR*-F          GCTTTGAACCCTTGATATTG                           5′UTR                       60.0
  *5′UTR*-R          CCGACCACGACAAAAGGACC                           Exon 1                      
  *CDS*-F            GCTGGCCGCACGACTGCACG                           Exon 1           1687       61.0
  *CDS*-R            GGGCACTGAAGGGAGAAAGG                           3′UTR                       
  *Intron1*-F        GCTGGCCGCACGACTGCACG                           Exon 1           946        60.0
  *Intron1*-R        AGCGGCAGCATCTTGTTCTT                           Exon 2                      
  *Intron2*-F        CGGGAGGCGCTGAGAACTG                            Exon 2           681        58.0
  *Intron2*-R        GGTGAAGTCACGCAGCCTT                            Exon 3                      
  *GLGI*-F           CATGGGACTCCAGATCTTGAG                                                      60.9
  *GLGI*-R           ACTATCTAGAGCGGCCGCTT                                                       
  *3′*-GSP           GCGGGGGTGGTGACTTGGAGAACACT                     Exon 3                      
  *miR-155-*F        TAAAAAGGACAGGAATACA                                             653        60.0
  *miR-155-*R        CAAGTCTTCAGATACAATG                                                        
  *EXP*-F            TTCCCAAGGCTGCGTGAC                             Exon 3           210        60.0
  *EXP*-R            CACCACTGTGCGGTTTGC                             Exon 3                      
  *GAPDH-*F          GGGCATGAACCATGAGAAGT                                            233        60.0
  *GAPDH-*R          AAGCAGGGATGATGTTCTGG                                                       
  *ssc-miR-155-*RT   CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTACCCCTA                               
  *ssc-miR-155-*F    GGAGGTTAATGCTAATTGTGATAG                                        65         56.0
  *ssc-miR-155-*R    CTCAACTGGTGTCGTGGAGTC                                                      
  *U6-*F             GCTTCGGCAGCACATATACTAAAAT                                       89         56.0
  *U6-*R             CGCTTCACGAATTTGCGTGTCAT                                                    
  *3′-UTR*-F         GGGAGCTGGTCTTTGTTTT                            3′UTR            485        60.0
  *3′-UTR*-R         TTTGCAGAGGATTTTCCTT                            3′UTR                       

###### 

The exon ⁄ intron organizations of porcine *OLFML3* gene.

  No.   Exon size (bp)   Intron size (bp)   5\' splice donor   3\' Splice acceptor
  ----- ---------------- ------------------ ------------------ ---------------------
  1     114              704                                   TTAGAG*gtaagt*
  2     289              324                *cttcag*GAACGG     TGACAG*gtaagt*
  3     821                                 *caccag*ACTGTG     

Coding sequences are shown in uppercase letters; noncoding regions are in lowercase letters. The conserved GT ⁄ AG junctions are shown in italic font.
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